David Tsay, M.D., was appointed chief medical officer of Counterpart Health, a Clover Health subsidiary, this month. | Clover ...

Company’s affordable, benefit-rich flagship PPO plans now have 4 Star ratingFRANKLIN, Tenn., Oct. 15, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CLOV) (“Clover” or “the Company”) has announced the debut of ...

Analyst Richard Close from Canaccord Genuity maintained a Buy rating on Clover Health Investments (CLOV – Research Report) and keeping ...

Federal Contracting Disclaimer: Clover Health is a Preferred Provider Organization (PPO) and a Health Maintenance Organization (HMO) with a Medicare contract. Enrollment in Clover Health depends on ...

A research team has identified a wealth of bioactive compounds in red clover (Trifolium pratense) seeds and their oil, ...

A research team has identified a wealth of bioactive compounds in red clover (Trifolium pratense ) seeds and their oil, ...

Fintel reports that on October 7, 2024, UBS initiated coverage of Clover Health Investments (NasdaqGS:CLOV) with a Neutral ...

Clover Health (CLOV) stock gains and Humana (HUM) stock falls as the Centers for Medicare & Medicaid Services ...

Clover Health Investments shares are trading higher by 4.6% Friday afternoon. The company announced that CMS raised its PPO Medicare Advantage plans' Star rating to 4 Stars for 2025.

Corn crops have a voracious appetite for nitrogen. Purdue University scientists are investigating whether mulching Kura ...

On Friday, Clover Health Investments Corp (CLOV) stock saw a modest uptick, ending the day at $4.07 which represents a slight increase of $0.12 or 3.04% from the prior close of $3.95. The stock opened ...